GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VitaSpring Biomedical Co Ltd (OTCPK:VSBC) » Definitions » Gross Margin %

VitaSpring Biomedical Co (VitaSpring Biomedical Co) Gross Margin % : 0.00% (As of Oct. 2022)


View and export this data going back to 2019. Start your Free Trial

What is VitaSpring Biomedical Co Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. VitaSpring Biomedical Co's Gross Profit for the three months ended in Oct. 2022 was $0.00 Mil. VitaSpring Biomedical Co's Revenue for the three months ended in Oct. 2022 was $0.00 Mil. Therefore, VitaSpring Biomedical Co's Gross Margin % for the quarter that ended in Oct. 2022 was 0.00%. If there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.


The historical rank and industry rank for VitaSpring Biomedical Co's Gross Margin % or its related term are showing as below:


VSBC's Gross Margin % is not ranked *
in the Biotechnology industry.
Industry Median: 59.905
* Ranked among companies with meaningful Gross Margin % only.

VitaSpring Biomedical Co had a gross margin of N/A% for the quarter that ended in Oct. 2022 => No sustainable competitive advantage

The 5-Year average Growth Rate of Gross Margin for VitaSpring Biomedical Co was 0.00% per year.


VitaSpring Biomedical Co Gross Margin % Historical Data

The historical data trend for VitaSpring Biomedical Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VitaSpring Biomedical Co Gross Margin % Chart

VitaSpring Biomedical Co Annual Data
Trend Jan17 Jan18 Jan19 Jan20 Jan21 Jan22
Gross Margin %
Get a 7-Day Free Trial 68.75 82.35 13.33 45.16 36.84

VitaSpring Biomedical Co Quarterly Data
Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.00 42.05 38.12 - -

Competitive Comparison of VitaSpring Biomedical Co's Gross Margin %

For the Biotechnology subindustry, VitaSpring Biomedical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


VitaSpring Biomedical Co's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VitaSpring Biomedical Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where VitaSpring Biomedical Co's Gross Margin % falls into.



VitaSpring Biomedical Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

VitaSpring Biomedical Co's Gross Margin for the fiscal year that ended in Jan. 2022 is calculated as

Gross Margin % (A: Jan. 2022 )=Gross Profit (A: Jan. 2022 ) / Revenue (A: Jan. 2022 )
=2.1 / 5.613
=(Revenue - Cost of Goods Sold) / Revenue
=(5.613 - 3.545) / 5.613
=36.84 %

VitaSpring Biomedical Co's Gross Margin for the quarter that ended in Oct. 2022 is calculated as


Gross Margin % (Q: Oct. 2022 )=Gross Profit (Q: Oct. 2022 ) / Revenue (Q: Oct. 2022 )
=0 / 0
=(Revenue - Cost of Goods Sold) / Revenue
=(0 - 0) / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


VitaSpring Biomedical Co  (OTCPK:VSBC) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

VitaSpring Biomedical Co had a gross margin of N/A% for the quarter that ended in Oct. 2022 => No sustainable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


VitaSpring Biomedical Co Gross Margin % Related Terms

Thank you for viewing the detailed overview of VitaSpring Biomedical Co's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


VitaSpring Biomedical Co (VitaSpring Biomedical Co) Business Description

Traded in Other Exchanges
N/A
Address
400 Spectrum Center Dr. No. 1620, Irvine, CA, USA, 92618
VitaSpring Biomedical Co Ltd is a start-up business company. The company's objective is to develop new drugs in cell medicine. The company also plans to produce X.MSC cytopharmaceuticals.

VitaSpring Biomedical Co (VitaSpring Biomedical Co) Headlines

No Headlines